Abstract:Background Deep learning has made tremendous successes in numerous artificial intelligence applications and is unsurprisingly penetrating into various biomedical domains. High-throughput omics data in the form of molecular profile matrices, such as transcriptomes and metabolomes, have long existed as a valuable resource for facilitating diagnosis of patient statuses/stages. It is timely imperative to compare deep learning neural networks against classical machine learning methods in the setting of matrix-formed omics data in terms of classification accuracy and robustness. Results Using 37 high throughput omics datasets, covering transcriptomes and metabolomes, we evaluated the classification power of deep learning compared to traditional machine learning methods. Representative deep learning methods, Multi-Layer Perceptrons (MLP) and Convolutional Neural Networks (CNN), were deployed and explored in seeking optimal architectures for the best classification performance. Together with five classical supervised classification methods (Linear Discriminant Analysis, Multinomial Logistic Regression, Naïve Bayes, Random Forest, Support Vector Machine), MLP and CNN were comparatively tested on the 37 datasets to predict disease stages or to discriminate diseased samples from normal samples. MLPs achieved the highest overall accuracy among all methods tested. More thorough analyses revealed that single hidden layer MLPs with ample hidden units outperformed deeper MLPs. Furthermore, MLP was one of the most robust methods against imbalanced class composition and inaccurate class labels. Conclusion Our results concluded that shallow MLPs (of one or two hidden layers) with ample hidden neurons are sufficient to achieve superior and robust classification performance in exploiting numerical matrix-formed omics data for diagnosis purpose. Specific observations regarding optimal network width, class imbalance tolerance, and inaccurate labeling tolerance will inform future improvement of neural network applications on functional genomics data.

Comparing deep belief networks with support vector machines for classifying gene expression data from complex disorders

CompareSVM: supervised, Support Vector Machine (SVM) inference of gene regularity networks

Applying the Deep Learning Techniques to Solve Classification Tasks Using Gene Expression Data

Discovering gene regulatory networks of multiple phenotypic groups using dynamic Bayesian networks

Integrative data analysis of multi-platform cancer data with a multimodal deep learning approach

DeepGene: an Advanced Cancer Type Classifier Based on Deep Learning and Somatic Point Mutations

Classifying Breast Cancer Subtypes Using Deep Neural Networks Based on Multi-Omics Data

Classifying Dna Microarray For Cancer Diagnosis Via Method Based On Complex Networks

Deep Learning Based Tumor Type Classification Using Gene Expression Data

A Comparative Analysis of Gene Expression Profiling by Statistical and Machine Learning Approaches

Multiclass cancer classification using gene expression profiling and probabilistic neural networks

Deep-Learning-Based Cancer Profiles Classification Using Gene Expression Data Profile

A Disease Network-Based Deep Learning Approach for Characterizing Melanoma.

Comparison of Discrimination Methods for the Classification of Tumors Using Gene Expression Data

Architectures and accuracy of artificial neural network for disease classification from omics data

Convergent learning-based model for leukemia classification from gene expression

Deep Learning for identifying radiogenomic associations in breast cancer

Gene Expression Classification: Decision Trees Vs. SVMs.

A Contrastive-Learning-Based Deep Neural Network for Cancer Subtyping by Integrating Multi-Omics Data

Assessment of deep learning and transfer learning for cancer prediction based on gene expression data

Enhancing Breast Cancer Prediction through Deep Learning and Comparative Analysis of Gene Expression and DNA Methylation Data using Convolutional Neural Networks